247 related articles for article (PubMed ID: 20451879)
21. [Biological markers in the diagnosis of dementia and Alzheimer's disease].
Meiner Z; Rosenmann H
Harefuah; 2012 May; 151(5):289-93, 318. PubMed ID: 22844733
[TBL] [Abstract][Full Text] [Related]
22. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.
Jagust WJ; Bandy D; Chen K; Foster NL; Landau SM; Mathis CA; Price JC; Reiman EM; Skovronsky D; Koeppe RA;
Alzheimers Dement; 2010 May; 6(3):221-9. PubMed ID: 20451870
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age.
Buckley R; Saling MM; Ames D; Rowe CC; Lautenschlager NT; Macaulay SL; Martins RN; Masters CL; O'Meara T; Savage G; Szoeke C; Villemagne VL; Ellis KA;
Int Psychogeriatr; 2013 Aug; 25(8):1307-15. PubMed ID: 23693133
[TBL] [Abstract][Full Text] [Related]
24. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study.
Burnham SC; Faux NG; Wilson W; Laws SM; Ames D; Bedo J; Bush AI; Doecke JD; Ellis KA; Head R; Jones G; Kiiveri H; Martins RN; Rembach A; Rowe CC; Salvado O; Macaulay SL; Masters CL; Villemagne VL; ;
Mol Psychiatry; 2014 Apr; 19(4):519-26. PubMed ID: 23628985
[TBL] [Abstract][Full Text] [Related]
25. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Lim YY; Ellis KA; Harrington K; Ames D; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Darby D; Maruff P; The Aibl Research Group
J Clin Exp Neuropsychol; 2012; 34(4):345-58. PubMed ID: 22248010
[TBL] [Abstract][Full Text] [Related]
26. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H
J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677
[TBL] [Abstract][Full Text] [Related]
27. Neuroimaging in dementias.
de Souza LC; Lehéricy S; Dubois B; Stella F; Sarazin M
Curr Opin Psychiatry; 2012 Nov; 25(6):473-9. PubMed ID: 23037962
[TBL] [Abstract][Full Text] [Related]
28. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
Cavedo E; Redolfi A; Angeloni F; Babiloni C; Lizio R; Chiapparini L; Bruzzone MG; Aquino D; Sabatini U; Alesiani M; Cherubini A; Salvatore E; Soricelli A; Vernieri F; Scrascia F; Sinforiani E; Chiarati P; Bastianello S; Montella P; Corbo D; Tedeschi G; Marino S; Baglieri A; De Salvo S; Carducci F; Quattrocchi CC; Cobelli M; Frisoni GB
J Alzheimers Dis; 2014; 40(4):941-52. PubMed ID: 24577455
[TBL] [Abstract][Full Text] [Related]
29. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
Sona A; Zhang P; Ames D; Bush AI; Lautenschlager NT; Martins RN; Masters CL; Rowe CC; Szoeke C; Taddei K; Ellis KA;
Int Psychogeriatr; 2012 Feb; 24(2):197-204. PubMed ID: 21749739
[TBL] [Abstract][Full Text] [Related]
30. Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease.
Fowler C; Rainey-Smith SR; Bird S; Bomke J; Bourgeat P; Brown BM; Burnham SC; Bush AI; Chadunow C; Collins S; Doecke J; Doré V; Ellis KA; Evered L; Fazlollahi A; Fripp J; Gardener SL; Gibson S; Grenfell R; Harrison E; Head R; Jin L; Kamer A; Lamb F; Lautenschlager NT; Laws SM; Li QX; Lim L; Lim YY; Louey A; Macaulay SL; Mackintosh L; Martins RN; Maruff P; Masters CL; McBride S; Milicic L; Peretti M; Pertile K; Porter T; Radler M; Rembach A; Robertson J; Rodrigues M; Rowe CC; Rumble R; Salvado O; Savage G; Silbert B; Soh M; Sohrabi HR; Taddei K; Taddei T; Thai C; Trounson B; Tyrrell R; Vacher M; Varghese S; Villemagne VL; Weinborn M; Woodward M; Xia Y; Ames D;
J Alzheimers Dis Rep; 2021; 5(1):443-468. PubMed ID: 34368630
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney.
Sexton CE; Anstey KJ; Baldacci F; Barnum CJ; Barron AM; Blennow K; Brodaty H; Burnham S; Elahi FM; Götz J; Jeon YH; Koronyo-Hamaoui M; Landau SM; Lautenschlager NT; Laws SM; Lipnicki DM; Lu H; Masters CL; Moyle W; Nakamura A; Pasinetti GM; Rao N; Rowe C; Sachdev PS; Schofield PR; Sigurdsson EM; Smith K; Srikanth V; Szoeke C; Tansey MG; Whitmer R; Wilcock D; Wong TY; Bain LJ; Carrillo MC
Alzheimers Dement; 2022 Jan; 18(1):178-190. PubMed ID: 34058063
[TBL] [Abstract][Full Text] [Related]
32. Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer's Disease Neuroimaging Initiative.
Russo MJ; Cohen G; Chrem Mendez P; Campos J; Nahas FE; Surace EI; Vazquez S; Gustafson D; Guinjoan S; Allegri RF; Sevlever G
Neuropsychiatr Dis Treat; 2016; 12():2199-2206. PubMed ID: 27695331
[TBL] [Abstract][Full Text] [Related]
33. Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
Seibyl J; Zubal IG; Jennings D; Marek K; Doraiswamy PM
Expert Rev Neurother; 2011 Dec; 11(12):1783-93. PubMed ID: 22091601
[TBL] [Abstract][Full Text] [Related]
34. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
Jagust WJ; Landau SM; Koeppe RA; Reiman EM; Chen K; Mathis CA; Price JC; Foster NL; Wang AY
Alzheimers Dement; 2015 Jul; 11(7):757-71. PubMed ID: 26194311
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease.
Platt B; Welch A; Riedel G
Biochem Soc Trans; 2011 Aug; 39(4):874-80. PubMed ID: 21787316
[TBL] [Abstract][Full Text] [Related]
36. A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease.
Peters KR; Lynn Beattie B; Feldman HH; Illes J
Prog Neurobiol; 2013 Nov; 110():114-23. PubMed ID: 23348495
[TBL] [Abstract][Full Text] [Related]
37. Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
Weiner MW; Veitch DP
Alzheimers Dement; 2015 Jul; 11(7):730-3. PubMed ID: 26194308
[TBL] [Abstract][Full Text] [Related]
38. Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI.
Shishegar R; Cox T; Rolls D; Bourgeat P; Doré V; Lamb F; Robertson J; Laws SM; Porter T; Fripp J; Tosun D; Maruff P; Savage G; Rowe CC; Masters CL; Weiner MW; Villemagne VL; Burnham SC
Sci Rep; 2021 Dec; 11(1):23788. PubMed ID: 34893624
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
Jack CR; Barnes J; Bernstein MA; Borowski BJ; Brewer J; Clegg S; Dale AM; Carmichael O; Ching C; DeCarli C; Desikan RS; Fennema-Notestine C; Fjell AM; Fletcher E; Fox NC; Gunter J; Gutman BA; Holland D; Hua X; Insel P; Kantarci K; Killiany RJ; Krueger G; Leung KK; Mackin S; Maillard P; Malone IB; Mattsson N; McEvoy L; Modat M; Mueller S; Nosheny R; Ourselin S; Schuff N; Senjem ML; Simonson A; Thompson PM; Rettmann D; Vemuri P; Walhovd K; Zhao Y; Zuk S; Weiner M
Alzheimers Dement; 2015 Jul; 11(7):740-56. PubMed ID: 26194310
[TBL] [Abstract][Full Text] [Related]
40. [Pre-symptomatic detection of Alzheimer's disease and mild cognitive impairment].
Arai H
Rinsho Shinkeigaku; 2009 Nov; 49(11):838-40. PubMed ID: 20030225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
